Italy's An­geli­ni Phar­ma teams up with JCR on blood-brain bar­ri­er deal

An­geli­ni Phar­ma plans to pay Japan­ese phar­ma JCR Phar­ma­ceu­ti­cals more than $500 mil­lion as part of a re­search col­lab­o­ra­tion that fo­cus­es on the blood-brain bar­ri­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER